Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Movsas

Showing results (21-30 of 325) with videos related to

Pageof 33
Sort By:
International Journal of Radiation Oncology, Biology, Physics|May 14, 2015
Cultivating Tomorrow's Clinician Scientists: We Reap What We SowNeha Vapiwala, Drew Moghanaki, Benjamin Movsas
International Journal of Radiation Oncology, Biology, Physics|September 19, 2015
In Reply to MellNeha Vapiwala, Drew Moghanaki, Benjamin Movsas
Chest|January 16, 2003
Treatment of stage II non-small cell lung cancerWalter J Scott, John Howington, Benjamin Movsas, et al.
Seminars in Oncology|July 15, 2005
Amifostine in chemoradiation therapy for non-small cell lung cancer: review of experience and design of a phase II trial assessing subcutaneous and intravenous bolus administrationMaria Werner-Wasik, Corey Langer, Benjamin Movsas
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Capturing the patient perspective: patient-reported outcomes as clinical trial endpointsDeborah Watkins Bruner, Benjamin Movsas, Ethan Basch
Seminars in Oncology|February 24, 2005
Randomized phase II study of amifostine mucosal protection by either subcutaneous injection or rapid IV bolus for patients with inoperable stage II-IIIA/B or stage IV non-small cell lung cancer with oligometastases receiving concurrent radiochemotherapy with carboplatin and paclitaxel followed by optional consolidative chemotherapy: a follow-up study after RTOG 98-01Maria Werner-Wasik, Corey Langer, Benjamin Movsas
Hematology/Oncology Clinics of North America|April 4, 2006
Quality-of-life outcomes in oncologyFarzan Siddiqui, Lisa A Kachnic, Benjamin Movsas
Expert Review of Pharmacoeconomics & Outcomes Research|December 16, 2010
Quality-of-life concerns in lung cancer patientsFarzan Siddiqui, Andre A Konski, Benjamin Movsas
International Journal of Radiation Oncology, Biology, Physics|March 28, 2006
Pretreatment factors significantly influence quality of life in cancer patients: a Radiation Therapy Oncology Group (RTOG) analysisBenjamin Movsas, Charles Scott, Deborah Watkins-Bruner
Current Problems in Cancer|April 13, 2012
Thoracic radiotherapy for limited stage small cell lung carcinomaPaul D Aridgides, Benjamin Movsas, Jeffrey A Bogart
Pageof 33

Showing results (21-30 of 325) with videos related to

Sort By:
Pageof 33
International Journal of Radiation Oncology, Biology, Physics|May 14, 2015
Cultivating Tomorrow's Clinician Scientists: We Reap What We SowNeha Vapiwala, Drew Moghanaki, Benjamin Movsas
International Journal of Radiation Oncology, Biology, Physics|September 19, 2015
In Reply to MellNeha Vapiwala, Drew Moghanaki, Benjamin Movsas
Chest|January 16, 2003
Treatment of stage II non-small cell lung cancerWalter J Scott, John Howington, Benjamin Movsas, et al.
Seminars in Oncology|July 15, 2005
Amifostine in chemoradiation therapy for non-small cell lung cancer: review of experience and design of a phase II trial assessing subcutaneous and intravenous bolus administrationMaria Werner-Wasik, Corey Langer, Benjamin Movsas
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Capturing the patient perspective: patient-reported outcomes as clinical trial endpointsDeborah Watkins Bruner, Benjamin Movsas, Ethan Basch
Seminars in Oncology|February 24, 2005
Randomized phase II study of amifostine mucosal protection by either subcutaneous injection or rapid IV bolus for patients with inoperable stage II-IIIA/B or stage IV non-small cell lung cancer with oligometastases receiving concurrent radiochemotherapy with carboplatin and paclitaxel followed by optional consolidative chemotherapy: a follow-up study after RTOG 98-01Maria Werner-Wasik, Corey Langer, Benjamin Movsas
Hematology/Oncology Clinics of North America|April 4, 2006
Quality-of-life outcomes in oncologyFarzan Siddiqui, Lisa A Kachnic, Benjamin Movsas
Expert Review of Pharmacoeconomics & Outcomes Research|December 16, 2010
Quality-of-life concerns in lung cancer patientsFarzan Siddiqui, Andre A Konski, Benjamin Movsas
International Journal of Radiation Oncology, Biology, Physics|March 28, 2006
Pretreatment factors significantly influence quality of life in cancer patients: a Radiation Therapy Oncology Group (RTOG) analysisBenjamin Movsas, Charles Scott, Deborah Watkins-Bruner
Current Problems in Cancer|April 13, 2012
Thoracic radiotherapy for limited stage small cell lung carcinomaPaul D Aridgides, Benjamin Movsas, Jeffrey A Bogart
Pageof 33